A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT05923073 · RECRUITING
Trial details
- NCT number
- NCT05923073
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2027-10-27
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.